Particle.news
Download on the App Store

Palantir Posts Blowout Quarter, Bold 2026 Targets as Cognizant Adopts AIP for Healthcare

Investors are reassessing a high‑multiple stock against evidence of a fast‑growing commercial franchise.

Overview

  • Q4 2025 revenue jumped 70% year over year to $1.407 billion, with adjusted operating margin at 57% and earnings topping estimates.
  • Management guided 2026 revenue to about $7.19 billion with an ~71% adjusted operating margin and $3.925–$4.125 billion in adjusted free cash flow, and projected Q1 revenue of $1.532–$1.536 billion (~74% growth).
  • U.S. commercial revenue soared 137% to $507 million and included a record $1.3 billion in total contract value, a segment CEO Alex Karp said has transformed from a former “backwater.”
  • Cognizant announced it will integrate Palantir Foundry and AIP with its TriZetto healthcare platforms to embed governed, scalable AI into core workflows and regulated operations.
  • Shares remain volatile and expensive at roughly 47× 2026 revenue; RBC reiterated Underperform with a $50 target, the stock is about 25% below its high, director Alexander D. Moore sold 20,000 shares, and Palantir reports 954 customers.